Start free

CTT Pharmaceutical Holdings, Inc. (CTTH) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 16, 2026.

Filings shown
17
Open-market buys
17
Open-market sells
0
Buys, 10b5-1 box not checked
17 of 17

Counts cover the 17 most recent Form 4 filings Tradune holds for CTTH (filed Aug 10 – Nov 16, 2026); the score below covers only the trailing 90 days (0 buys, 0 sells). SEC EDGAR Form 4 filings for CTTH last checked Nov 21, 2026, 09:00 UTC; the latest CTTH filing Tradune holds was filed Nov 16, 2026. This is not guaranteed to be the complete record — see CTTH's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 13 filings Tradune holds for CTTH filed Aug 24 – Nov 16, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
CTT Pharmaceutical Holdings, Inc.CEO 13 0 68,380 — +$3,436

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

No notable activity
0 distinct buyers0 buy · 0 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at CTTH

Insiders reported 17 open-market purchases of CTTH between Aug 10, 2026 and Nov 16, 2026, across 1 distinct buyer. The most recent purchase was reported by CTT Pharmaceutical Holdings, Inc. (CEO) on Nov 12, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

CTT Pharmaceutical Holdings, Inc. CEO · filed Nov 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,500 $0.05 9,454,036 +0.0% Nov 12, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

CTT Pharmaceutical Holdings, Inc. CEO · filed Nov 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 9,000 $0.05 9,452,536 +0.1% Nov 4, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Oct 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,880 $0.06 9,442,536 +0.1% Oct 26, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,000 $0.06 9,436,656 +0.0% Oct 15, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Oct 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,700 $0.06 9,433,656 +0.0% Oct 6, 2026
CTT Pharmaceutical Holdings, Inc. amended CEO · filed Sep 29, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,100 $0.05 9,424,556 +0.1% Sep 22, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Sep 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,400 $0.06 9,429,956 +0.0% Sep 28, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Sep 16, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,900 $0.05 9,414,456 +0.1% Sep 16, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Sep 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,500 $0.05 9,400,556 +0.0% Sep 10, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Sep 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 9,800 $0.05 9,397,056 +0.1% Sep 4, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,000 $0.05 9,387,256 +0.0% Sep 2, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Aug 31, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 3,500 $0.05 9,384,256 +0.0% Aug 31, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 2,100 $0.06 9,360,756 +0.0% Aug 24, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Aug 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 11,500 $0.05 9,378,656 +0.1% Aug 20, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Aug 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,000 $0.06 9,365,456 +0.1% Aug 19, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Aug 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,800 $0.06 9,355,456 +0.0% Aug 14, 2026
CTT Pharmaceutical Holdings, Inc. CEO · filed Aug 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 7,700 $0.07 9,353,656 +0.1% Aug 7, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to CTTH's (Nov 16, 2026).

Frequently asked about CTTH insider activity

How many insiders bought CTTH stock in these Form 4 filings?

1 distinct insider at CTT Pharmaceutical Holdings, Inc. reported 17 open-market purchases (Form 4 code P) of CTTH shares between Aug 10, 2026 and Nov 16, 2026, the most recent filed by CTT Pharmaceutical Holdings, Inc. (CEO) on Nov 12, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for CTTH?

The most recent Form 4 on this page was filed by CTT Pharmaceutical Holdings, Inc. (CEO) on Nov 16, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market CTTH insider purchase shown?

The largest open-market purchase among the filings shown was 10,000 CTTH shares at $0.06 (about $590) by CTT Pharmaceutical Holdings, Inc. (CEO) on Aug 19, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent CTTH insider purchases have the Form 4 10b5-1 box checked?

No. All 17 CTTH open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: CTT Pharmaceutical Holdings, Inc. (CEO) on Nov 12, 2026, 1,500 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for CTTH — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.